NASDAQ: ACRS

Aclaris Therapeutics Inc (ACRS) is destined for greater heights as its last quarter sales were 1,780 K

Zack King

Aclaris Therapeutics Inc (NASDAQ: ACRS) on Friday, soared 6.42% from the previous trading day, before settling in for the closing ...

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.